Verwandte Artikel zu Tumors of the Central Nervous System, Volume 2: Gliomas:...
Zu dieser ISBN ist aktuell kein Angebot verfügbar.
Alle Exemplare der Ausgabe mit dieser ISBN anzeigen:
hard to find
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Reseña del editor:
Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
- VerlagSpringer
- Erscheinungsdatum2011
- ISBN 10 9400706170
- ISBN 13 9789400706170
- EinbandTapa dura
- Anzahl der Seiten458
- HerausgeberHayat M.A.
Neu kaufen
Mehr zu diesem Angebot erfahren
EUR 180,07
Versand:
EUR 48,99
Von Deutschland nach USA
Beste Suchergebnisse bei AbeBooks
Foto des Verkäufers
Tumors of the Central Nervous System, Volume 2
Verlag:
Springer Netherlands
(2011)
ISBN 10: 9400706170
ISBN 13: 9789400706170
Neu
Hardcover
Anzahl: > 20
Anbieter:
Bewertung
Buchbeschreibung Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. 1. Targeted therapy determined by molecular genetics is emphasized. 2.Several imaging techniques for diagnosis and treatment assessment are detailed. 3.Present and future therapeutic drugs against malignant gliomas are described. 4.The anti-tumor action of . Bestandsnummer des Verkäufers 5825375
Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren
Neu kaufen
EUR 180,07
Währung umrechnen
Foto des Verkäufers
Tumors of the Central Nervous System, Volume 2
Verlag:
Springer Netherlands Apr 2011
(2011)
ISBN 10: 9400706170
ISBN 13: 9789400706170
Neu
Hardcover
Anzahl: 2
Anbieter:
Bewertung
Buchbeschreibung Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. 480 pp. Englisch. Bestandsnummer des Verkäufers 9789400706170
Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren
Neu kaufen
EUR 213,99
Währung umrechnen
Foto des Verkäufers
Tumors of the Central Nervous System, Volume 2 : Gliomas: Glioblastoma (Part 2)
Verlag:
Springer Netherlands
(2011)
ISBN 10: 9400706170
ISBN 13: 9789400706170
Neu
Hardcover
Anzahl: 1
Anbieter:
Bewertung
Buchbeschreibung Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. Bestandsnummer des Verkäufers 9789400706170
Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren
Neu kaufen
EUR 217,79
Währung umrechnen